Wingerchuk DM , Hogancamp WF, O’Brien PC and Weinshenker BGThe clinical course of neuromyelitis optica (Devic’s syndrome). Neurology1999; 53: 1107-1114.
2.
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet2004; 364: 2106-2112.
3.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS and Hinson SRIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med2005; 202: 473-477.
4.
Waters P. and Vincent A.Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J2008; 15: 99-105.
5.
Wingerchuk DM , Lennon VA, Pittock SJ, Lucchinetti CF and Weinshenker BGRevised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485-1489.
6.
Tanaka A., Yoshida T., Yamada T., et al. A case of cerebral aquaporinopathy. Mult Scler2010; 00: 000-000.
7.
Kim JS, Park YH, Kim SM, et al. A case of chronic progressive myelopathy. Mult Scler2010; 00: 000-000.
8.
Nozaki H., Shimohata T., Kanbayashi T., et al. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med2009; 10: 253-255.
9.
Baba T., Nakashima I., Kanbayashi T., et al. Narcolepsy as an intial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. J Neurol2009 ; 256: 287-288.
10.
Takahashi T. , Miyazawa I., Misu T., et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry2008; 79: 1075-1078.
11.
Thomson AJ, Montalban X., Barkhof F., et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol2000; 47: 831-835.
12.
Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA and Weinshenker BGA secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology2007; 68: 603-605.
13.
Pittock SJ, Lennon VA, Krecke K., Wingerchuk DM, Lucchinetti CF and Weinshenker BGBrain abnormalities in neuromyelitis optica. Arch Neurol2006; 63: 390-396.
14.
Misu T., Fujihara K., Nakamura M., et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med2006 ; 209: 269-275.
15.
Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain2007; 130: 1194-1205.
16.
Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain2007; 130: 1224-1234.
17.
Misu T., Takano R., Fujihara K., Takahashi T., Sato S. and Itoyama Y.Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry2009; 80: 575-577.
18.
Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology2007; 69: 2221-2231.
19.
Kinoshita M. , Nakatsuji Y., Moriya M., et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport2009; 20: 508-512.
20.
Kinoshita M. , Nakatsuji Y., Kimura T., et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun2009; 386: 623-627.
21.
Bennett JL, Lam C., Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol2009; 66: 617-629.
22.
Bradl M., Misu T., Takahashi T., et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol2009; 66: 630-643.
23.
Kinoshita M. , Nakatsuji Y., Kimura T., et al. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun2010; 394: 205-210.
24.
Carroll WM and Fujihara K.Neuromyelitis optica. Curr Treat Options Neurol, (in press).
25.
Watanabe S. , Nakashima I., Misu T., et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler2007; 13: 128-132.